Chinook Therapeutics Inc.

Q3 2020 13F Holders

Symbol
KDNY
CUSIP
00739L101
Type
Equity
Class
COM
Num filings
68
Total reported value, excl. options
$81.8 M
Manager Report Date Value ($000) Shares Option Type